Angiotensin AT2 receptors: control of renal sodium excretion and blood pressure

Trends in Endocrinology and Metabolism

Volumn 19, Issue 3, 2008, Pages 84-87

  Carey, Robert M ^a   Padia, Shetal H ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN III; ANGIOTENSIN RECEPTOR ANTAGONIST; RENIN; SODIUM;

BLOOD PRESSURE; DRUG INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; REVIEW; SODIUM URINE LEVEL; UPREGULATION; VASODILATATION; HUMAN; KIDNEY; METABOLISM; NATRIURESIS; PHYSIOLOGY; URINE;

BLOOD PRESSURE; HUMANS; KIDNEY; NATRIURESIS; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN; SODIUM; VASODILATION;

EID: 41149099225     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2008.01.003     Document Type: Review

References (44)

1. de Gasparo M., et al. International Union of Pharmacology XXIII. The angiotensin II receptors. Pharmacol. Rev. 52 (2000) 415-472
2. Schiffrin E.L., and Touyz R.M. From bench to bedside: role of the renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H1435-H1446
3. Mehta P.K., and Griendling K.K. Angiotensin II signaling: physiological and pathological effects in the cardiovascular system. Am. J. Physiol. Cell Physiol. 292 (2007) C82-C97
4. Berry C., et al. Angiotensin receptors: signaling, vascular pathophysiology and interaction with ceramide. Am. J. Physiol. Heart Circ. Physiol. 281 (2001) H2337-H2365
5. Widdop R.E., et al. Angiotensin AT2 receptors: cardiovascular hope or hype?. Br. J. Pharmacol. 140 (2003) 809-824
6. 1 receptor-mediated prostaglandin (PG) E2 production in conscious rats. J. Clin. Invest. 97 (1996) 1978-1982
7. Siragy H.M., et al. Renin-angiotensin system modulates renal bradykinin production. Am. J. Physiol. 271 (1996) R1090-R1095
8. Siragy H.M., and Carey R.M. The subtype-2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J. Clin. Invest. 100 (1997) 264-269
9. 2 and nitric oxide. Hypertension 29 (1997) 757-762
10. Tsutsumi Y., et al. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J. Clin. Invest. 104 (1999) 925-935
11. Abadir P.M., et al. Angiotensin AT2 receptors directly stimulate renal nitric oxide in bradykinin B2-receptor-null mice. Hypertension 42 (2003) 600-604
12. Carey R.M. Cardiovascular and renal regulation by the angiotensin AT2 receptor: the AT2 receptor comes of age. Hypertension 45 (2005) 840-844
13. Carey R.M., et al. Angiotensin type-2 receptor-mediated hypotension in angiotensin type-1 receptor-blocked rats. Hypertension 38 (2001) 1272-1277
14. 1 receptor blockade. Hypertension 40 (2002) 516-520
15. 2 receptor in a renal wrap hypertension model. Hypertension 33 (1999) 1237-1243
16. Siragy H.M., et al. Angiotensin type-2 receptor mediates valsartan-induced hypotension in conscious rats. Hypertension 35 (2000) 1074-1077
17. 1 receptor-mediated contraction in the rat uterine artery: involvement of bradykinin and nitric oxide. Br. J. Pharmacol. 140 (2003) 987-996
18. Buriell J.H., and Limbus E.R. Angiotensin receptor subtypes in the uterine artery during ovine pregnancy. Br. J. Pharmacol. 330 (1997) 257-267
19. 2 receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions. Br. J. Pharmacol. 136 (2002) 484-491
20. 2 receptors. Circ. Res. 94 (2004) 1623-1629
21. Perlegas D., et al. The angiotensin type-2 receptor regulates smooth muscle growth and force generation in late fetal mouse development. Am. J. Physiol. Heart Circ. Physiol. 288 (2005) H96-H102
22. 2 receptor. J. Pharmacol. Exp. Ther. 307 (2004) 1171-1178
23. Gauthier K.M., et al. Angiotensin II dilates bovine adrenal cortical arterioles: role of endothelial nitric oxide. Endocrinology 146 (2005) 3319-3324
24. Batenburg W.W., et al. Angiotensin II type-2 receptor-mediated vasodilation in human coronary micro-arteries. Circulation 109 (2004) 2296-2301
25. Savoia C., et al. Angiotensin II/AT2 receptor induced vasodilation in stroke-prone spontaneously hypertensive rats involves nitric oxide and cGMP-dependent protein kinase. J. Hypertens. 24 (2006) 2417-2422
26. Savoia C., et al. Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients. Hypertension 49 (2007) 341-346
27. Yayama K., et al. Up-regulation of angiotensin II type 2 receptor in rat thoracic aorta by pressure-overload. J. Pharmacol. Exp. Ther. 308 (2004) 736-743
28. 2 receptors in the pressure-overloaded aorta after banding. Hypertension 43 (2004) 1258-1263
29. Yayama K., et al. Angiotensin II stimulates endothelial NO synthase phosphorylation in thoracic aorta of mice with abdominal aortic banding via type 2 receptor. Hypertension 48 (2006) 958-964
30. Bonnet F., et al. Vascular expression of angiotensin type 2 receptor in the adult rat: influence of angiotensin II infusion. J. Hypertens. 19 (2001) 1075-1081
31. Ozono R., et al. Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 30 (1997) 1238-1246
32. Miyata N., et al. Distribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidney. Am. J. Physiol. Renal Physiol. 277 (1999) F437-F446
33. 2 receptor: signaling and transport. J. Am. Soc. Nephrol. 10 suppl II (1999) S69-S74
34. 2) angiotensin receptor. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 6506-6510
35. 2 receptor. Kidney Int. 57 (2000) 191-202
36. 2 knockout mice. Biochem. Biophys. Res. Commun. 258 (1999) 194-198
37. Padia S.H., et al. Renal angiotensin type-2 receptors mediate natriuresis via angiotensin III in angiotensin II type-1 receptor blocked rats. Hypertension 47 (2006) 537-544
38. Padia S.H., et al. Intrarenal aminopeptidase N inhibition augments natriuretic responses to angiotensin III in angiotensin type-1 receptor-blocked rats. Hypertension 49 (2007) 625-630
39. Salomone L.J., et al. Intrarenal dopamine D1-like receptor stimulation induces natriuresis via an angiotensin type-2 receptor mechanism. Hypertension 49 (2007) 155-161
40. Reaux-Le Goazigo A., et al. Role of angiotensin III in hypertension. Curr. Hypertens. Rep. 7 (2005) 128-134
41. Hakam A.C., and Hussain T. Renal AT2 receptors are upregulated and mediate the candesartan-induced natriuresis/diuresis in obese Zucker rats. Hypertension 45 (2005) 270-275
42. Hakam A.C., and Hussain T. Renal angiotensin AT2 receptors promote natriuresis in streptozotocin-induced diabetic rats. Am. J. Physiol. Renal Physiol. 290 (2006) F503-F508
43. Carey R.M., et al. The renal dopamine system: paracrine regulator of sodium homeostasis and blood pressure. Hypertension 38 (2001) 297-302
44. Siragy H.M., et al. Angiotensin subtype-2 receptors inhibit renin biosynthesis and angiotensin II formation. Hypertension 45 (2005) 133-137